Article Details
Retrieved on: 2018-02-19 03:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc increased its stake in Valeant Pharmaceuticals Intl (VRX) by 4.91% based on its latest 2017Q3 regulatory filing with the SEC. <b>Vanguard Group</b> Inc bought 356,925 shares as the company's stock declined 15.71% while stock markets rallied. The institutional investor held 7.63 million ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here